A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant

NCT03099122 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

End-stage Renal Disease

Interventions

BIOLOGICAL: Rabbit Anti-thymocyte Immunoglobulin
DRUG: Tacrolimus
DRUG: Methylprednisolone
DRUG: Mycophenolate mofetil
DRUG: Mycophenolate Na
DRUG: prednisone

Sponsor

Sanofi